Aprea Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
/ 
Frequently asked questions
To buy Aprea Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aprea Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aprea Therapeutics Inc. is APRE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aprea Therapeutics Inc. has its primary listing on NASDAQ. You can trade Aprea Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aprea Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Aprea Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Aprea Therapeutics Inc..